Stocktoria

PolyPid Ltd. PYPD

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-06-26
Chart by TradingView
2/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Operating income-$33.0M-$28.0M-$22.9M-$38.9M-$43.1M
Net income-$34.2M-$29.0M-$23.9M-$39.6M-$42.6M
Operating cash flow-$27.9M-$22.0M-$17.2M-$34.3M-$32.4M
Free cash flow-$28.1M-$22.0M-$17.4M-$36.1M-$35.0M
Total assets$22.3M$25.2M$15.4M$26.0M$44.2M
Shareholders' equity$11.0M$7.7M-$2.1M$5.8M$36.0M
Ratios
Return on assets-153.2%-115.1%-155.2%-152.3%-96.3%
Return on equity-311.4%-377.7%1138.6%-678.6%-118.5%
Debt / equity0.08×-3.04×
Current ratio1.971.310.831.664.31

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001611842 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.